Navigation Links
Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
Date:7/24/2013

SUNNYVALE, Calif., July 24, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today announced that it will report financial results and recent developments for its second quarter ended June 30, 2013 after the NASDAQ Market closes on Wednesday, July 31, 2013.  The Company will conduct a conference call and audio webcast at 4:30 p.m ET on the same day.

Conference call and webcast details:

Date: July 31, 2013
Time: 4:30 PM ET
Listen via Internet: http://ir.pharmacyclics.com/events.cfm
Toll-free: (877) 303-7908
International: (678) 373-0875

Replay Number (Toll Free): (855) 859-2056
Replay Number (International): (404) 537-3406
Conference ID #: 23863642

A webcast replay will be available on the Pharmacyclics website for 30 days.

About Pharmacyclics
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercia
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacyclics Reports First Quarter 2013 Results
2. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
3. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
4. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
5. Pharmacyclics, Inc. Prices Public Offering of Common Stock
6. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
7. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
8. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
9. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
10. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
11. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 Legal-Bay LLC, The Lawsuit Settlement ... and cash advance funding for victims who suffer ... Robot. With over 400k surgeries performed per year ... lawsuit cash advances for victims with injuries such ... internal organs, burns to blood vessels or organs, ...
(Date:9/1/2014)... NEW YORK , Sept. 1, 2014 /PRNewswire/ ... report is available in its catalogue:  Drug ... http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html ... diseases, such as cancer requires extensive expenditure, in ... first step in designing a new drug involves ...
(Date:8/30/2014)... Aug. 30, 2014   Royal Philips  (NYSE: PHG, ... a new ultrasound system designed to enable global ... increasing patient volumes and cost pressures. Making its debut ... in Barcelona this week, Affiniti ... patients with fewer resources deliver high quality patient care. ...
Breaking Medicine Technology:da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 3Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11Drug Discovery Technologies - A Global Market Overview 12Drug Discovery Technologies - A Global Market Overview 13Drug Discovery Technologies - A Global Market Overview 14Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... ... that a new market research report is available in ... A Worldwide Market Review , http://www.reportlinker.com/p0164283/Decubitus-Ulcer-Treatment-Products---A-Worldwide-Market-Review.html ... damage caused by constant pressure of the patient,s bodyweight. ...
... , KING OF PRUSSIA, Pa., Nov. 30 ... Phase I study of CPSI-2364, its orally active, small-molecule inhibitor ... Results of the safety and tolerability dose escalation study in ... clinical testing. , All 30 enrolled subjects completed ...
Cached Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2
(Date:9/2/2014)... (PRWEB) September 02, 2014 QueenBeeTickets.com , ... events, is now stocking James Taylor concert tickets for the ... select U.S. cities from November 1 to the 19th. , ... and again on the 4th of the month. General onsales ... fans are all set to obtain seats for one of ...
(Date:9/2/2014)... ZAMST, a leader in high-performance sports ... professional baseball star Nolan Arenado . Widely ... players, Arenado will be working with Zamst to continue ... category. , Arenado was selected by Colorado in the ... 2013, Arenado was awarded the Gold Glove, putting him ...
(Date:9/2/2014)... Texas (PRWEB) September 02, 2014 At ... Prosupps will be an exhibitor at the ... Paradise Rd, Las Vegas, NV 89109 Booth #374 Sept ... is to encourage healthy living through exercise, diet and ... this vision, and provide the tools for all Prosupps ...
(Date:9/2/2014)... Tuesday 2 September 2014: A simple awareness campaign in ... according to research presented at ESC Congress today by ... "Atrial fibrillation (AF) is the most common cardiac arrhythmia. ... three-fold and the risk of stroke risk by five-fold. ... of 4 cases. However, AF is often overlooked and ...
(Date:9/2/2014)... Tuesday 2 September 2014: The fact that mechanical heart ... confirmed by data from the ROPAC registry presented for ... Line session by Professor Jolien W. Roos-Hesselink, co-chair with ... registry found that 1.4% of pregnant women with a ... during pregnancy. , The Registry Of Pregnancy And Cardiac ...
Breaking Medicine News(10 mins):Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:Prosupps, One of the Fastest Growing Supplement Companies, Celebrates a Success Milestone with Exhibiting at the 50th Annual 2014 Mr. Olympia’s Fitness & Performance Expo 2Health News:Simple awareness campaign in general practice identifies new cases of AF 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3
... Neighborhood Council, Friends of Hermon Dog ... 7 If, as the saying goes, every dog,is destined to ... on July 19, 2008, in the Northeast Los Angeles community of,Hermon, ... along with the,people who take them home., For the third ...
... either spontaneously or with assisted reproductive technology (ART) suffer ... later than do parents of singleton babies, according to ... European Society of Human Reproduction and Embryology in Barcelona ... twins had fewer symptoms of depression before the birth ...
... Colonial Life & Accident,Insurance Company is the ... according to Eastbridge Consulting Group,s 2007,U.S. Worksite Sales ... Colonial Life ranked second on the annual study,s ... of $334.9 million last year, worth a,market share ...
... N.J., July 7 The Peer Group, a ... industry, and an,Informed Medical Communications (IMC) company, today ... the newest innovation in moderated,peer influence events whereby ... utilizing clinical data, product attributes, and prescribing,experience in ...
... July 7, 2008 Vaccinating infants and toddlers is an ... flu are a regular part of medical care for senior ... in the August 2008 issue of the American Journal ... very effective in getting vaccines to the adolescent population. , ...
... study says , , MONDAY, July 7 (HealthDay News) -- The ... middle schools or high schools are far less healthy than ... study suggests. , The researchers based their conclusion on a ... schools spread across 129 school districts in 38 states, as ...
Cached Medicine News:Health News:'Dog Days of Summer' Festival Brings Pet Adoptions, Dog-Centric Family Fun Back to Hermon Park 2Health News:Parents of twins report more mental health symptoms than parents of singletons 2Health News:Parents of twins report more mental health symptoms than parents of singletons 3Health News:Parents of twins report more mental health symptoms than parents of singletons 4Health News:Colonial Life Number Two in Worksite Sales 2Health News:The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs 2Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 2Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 3Health News:Secondary Schools Serve Unhealthy Foods 2Health News:Secondary Schools Serve Unhealthy Foods 3
Indications For Usage: ,Jet ventilation....
Indications For Usage: , Airway management during surgical procedures. , Long-term ventilatory management. ...
Indications For Usage: , Oral Surgery. , Maxillofacial surgery. ...
The Cuffed Endoflex endotracheal tube had a murphy eye, high volume, low pressure cuff., ,Endoflex endotracheal tubes are individual packaged in sterilized pouches, 10 units per box, 10 boxes pe...
Medicine Products: